Clinical review pending. This article has not yet been reviewed by a licensed clinician, and we would rather say so than print a name that does not exist.
This is general regulatory context for practices. It is not legal or clinical advice, and it names no product or pharmacy.
When a practice sends a patient-specific prescription to a pharmacy, the quality of that pharmacy becomes part of the patient's care. FDA is plain about the risk: poor practices can lead to serious quality problems, such as contamination or a medicine with too much or too little active ingredient, and that can lead to serious patient injury. Choosing a partner carefully is one of the most useful things a practice can do.
Here is a practical way to work through it.
1. Licensure
Start with the license. FDA explains that state boards of pharmacy generally have primary responsibility for day-to-day oversight of state-licensed pharmacies that are not registered with FDA as outsourcing facilities. FDA also notes that states are primarily responsible for the day-to-day oversight of the vast majority of these pharmacies, most of which do not register with FDA.
Most state boards publish a public license lookup. The Virginia Board of Pharmacy, for example, licenses and regulates pharmacists, pharmacy technicians, and pharmacies, and its public License Lookup lets the public review the status of a license, with separate categories for a pharmacy and a non-resident pharmacy.
Questions to answer:
- Is the pharmacy licensed in the state where it operates?
- Is it licensed or registered in the states where your patients live, if those rules apply?
- Is the license active, and has the board taken any action against it?
2. Inspection and enforcement history
FDA does conduct surveillance and for-cause inspections of state-licensed pharmacies. Its page on inspections, recalls, and other actions lists many facilities by name, with documents such as Form 483s, warning letters, and referral letters to state boards of pharmacy. It also points to FDA's enforcement report for recalls.
FDA and the states share information, including inspection findings, complaints, and adverse events. A clean record on one list does not mean the other has nothing, so check both.
Questions to answer:
- When was the pharmacy last inspected, and by whom?
- Were there observations, and how were they resolved?
- Has it had a recall?
3. Which category the partner is in
Ask the partner directly whether it operates under section 503A or is registered as an outsourcing facility under section 503B. The answer changes what rules apply.
- Under section 503A, a pharmacy works from valid patient-specific prescriptions. FDA notes that current good manufacturing practice requirements do not apply in this setting, although federal rules against insanitary conditions apply everywhere.
- Outsourcing facilities under section 503B follow current good manufacturing practice and are inspected by FDA on a risk-based schedule. FDA publishes a list of registered outsourcing facilities that shows each one's last inspection and whether a Form 483 was issued. That list covers outsourcing facilities only. It is not a way to check a 503A pharmacy.
4. Quality and communication
A good partner can answer plain questions without hesitation:
- What quality standards do you follow, and how do you show it?
- How do you handle a complaint or a suspected quality problem?
- How will you tell us if there is a recall?
- Who is our contact when a patient calls us with a concern?
5. How the partner talks about its products
Under federal law, prescription drug promotion, including by those who prepare compounded medicines, must be truthful and not misleading. Be cautious of any partner that describes a compounded medicine as approved, as a generic, or as the same as an approved product. Compounded medicines are not FDA-approved.
Where SiriusRx fits
Sirius Peptides, by SiriusRx, gives practices a workspace and managed ordering. SiriusRx works with practices. It does not sell to patients and it does not provide medical care. The prescriber decides every order, for a named patient.
References
- U.S. Food and Drug Administration. "Compounding and the FDA: Questions and Answers."
- U.S. Food and Drug Administration. "Compounding Information for States."
- U.S. Food and Drug Administration. "Compounding: Inspections, Recalls, and other Actions."
- U.S. Food and Drug Administration. "Registered Outsourcing Facilities."
- U.S. Food and Drug Administration. "Human Drug Compounding Laws."
- Virginia Department of Health Professions. "Virginia Board of Pharmacy."
- Virginia Department of Health Professions. "License Lookup."
These are public, peer reviewed sources about the underlying physiology. They are not studies of SiriusRx and they do not describe results anyone should expect from us.

